William L.  Roper net worth and biography

William Roper Biography and Net Worth

Director of The Cigna Group
William L. Roper M.D. is no longer serves as Independent Director of the Company effective 4/28/2021. He has served as Interim President of the University of North Carolina System since January 2019. He previously served as Dean of the School of Medicine and Vice Chancellor for Medical Affairs of the University of North Carolina (UNC) at Chapel Hill, an educational institution, and as Chief Executive Officer of the UNC Health Care System, a not-for-profit health care system from 2004 to 2019. He has also served as a Professor of Pediatrics and Social Medicine at the UNC School of Medicine and as a Professor of Health Policy and Administration at the UNC School of Public Health. Before joining UNC in 1997, Dr. Roper served as Senior Vice President of Prudential Health Care, a healthcare services company, from 1993 to 1997. He also served as director of the Centers for Disease Control and Prevention from 1990 to 1993, on the senior White House staff in 1989 and 1990 and as the administrator of the Centers of Medicare & Medicaid Services from 1986 to 1989. Dr. Roper received his Bachelor of Science and Medical degrees from the University of Alabama.

What is William L. Roper's net worth?

The estimated net worth of William L. Roper is at least $3.38 million as of May 5th, 2020. Dr. Roper owns 10,442 shares of The Cigna Group stock worth more than $3,376,525 as of November 21st. This net worth evaluation does not reflect any other investments that Dr. Roper may own. Learn More about William L. Roper's net worth.

How do I contact William L. Roper?

The corporate mailing address for Dr. Roper and other The Cigna Group executives is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. The Cigna Group can also be reached via phone at (860) 226-6000 and via email at [email protected]. Learn More on William L. Roper's contact information.

Has William L. Roper been buying or selling shares of The Cigna Group?

William L. Roper has not been actively trading shares of The Cigna Group during the last ninety days. Most recently, William L. Roper sold 2,819 shares of the business's stock in a transaction on Tuesday, May 5th. The shares were sold at an average price of $192.07, for a transaction totalling $541,445.33. Following the completion of the sale, the director now directly owns 10,442 shares of the company's stock, valued at $2,005,594.94. Learn More on William L. Roper's trading history.

Who are The Cigna Group's active insiders?

The Cigna Group's insider roster includes Mary Agolglia Hoeltzel (VP), Lisa Bacus (EVP), David Cordani (President, CEO & Chairman of the Board), William DeLaney, III (Director), Noelle Eder (EVP and Global Chief Information Officer), Brian Evanko (CFO), Brian Evanko (Exec. VP & CFO ), Eric Foss (Director), Elder Granger (Director), Isaiah Harris, Jr. (Chairman), Mary Hoeltzel (CAO), Nicole Jones (EVP), Matthew Manders (Insider), Thomas McCarthy (CFO), Steven Miller (EVP), Alan Muney (EVP), John Murabito (EVP), Everett Neville (EVP), Eric Palmer (CFO), John Partridge (Director), William Roper (Director), Cynthia Ryan (EVP), Jason Sadler (Insider), Paul Sanford (EVP), Michael Triplett (Insider), Timothy Wentworth (CEO), and Donna Zarcone (Director). Learn More on The Cigna Group's active insiders.

Are insiders buying or selling shares of The Cigna Group?

During the last year, insiders at the health services provider sold shares 17 times. They sold a total of 139,823 shares worth more than $48,194,208.52. The most recent insider tranaction occured on August, 19th when Director William J Delaney III sold 2,691 shares worth more than $922,151.88. Insiders at The Cigna Group own 0.7% of the company. Learn More about insider trades at The Cigna Group.

Information on this page was last updated on 8/19/2024.

William L. Roper Insider Trading History at The Cigna Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/5/2020Sell2,819$192.07$541,445.3310,442View SEC Filing Icon  
See Full Table

William L. Roper Buying and Selling Activity at The Cigna Group

This chart shows William L Roper's buying and selling at The Cigna Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

The Cigna Group Company Overview

The Cigna Group logo
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Read More

Today's Range

Now: $323.21
Low: $323.21
High: $324.45

50 Day Range

MA: $336.78
Low: $308.23
High: $367.07

2 Week Range

Now: $323.21
Low: $253.95
High: $370.83

Volume

1,863 shs

Average Volume

1,536,084 shs

Market Capitalization

$89.90 billion

P/E Ratio

30.49

Dividend Yield

1.74%

Beta

0.51